Company Overview and News

 
Invesco bets US$5.7 bil on bright future for active management

2018-10-19 theedgemarkets
Invesco agreed to pay about that amount in a deal with Massachusetts Mutual Life Insurance Co to acquire its OppenheimerFunds, which specializes in picking stocks and bonds, especially in the international arena. At a time when many investors are deserting active funds for products that track indexes, Invesco Chief Executive Officer Martin Flanagan is convinced active funds will continue to play a critical role in the portfolios of retail and institutional customers.
ABDNY SLFPF ADN SL HGG JHG ABDNF JNS SLFPY

1
Invesco to buy OppenheimerFunds, adding $246 billion in assets

2018-10-18 livemint - 1
Boston/Los Angeles/New York: Invesco Ltd is betting $5.7 billion that active management has a bright future.
ABDNY SLFPF ADN SL HGG JHG ABDNF JNS IVZ SLFPY

11
BlackRock wins US$40bil contract

2018-10-13 thestar.com.my
LONDON: Lloyds Banking Group has awarded BlackRock a £30bil (US$40bil) slice of one of Europe’s biggest investment contracts to be invested using the US company’s various index strategies.
SLFPF LLOY ADN SL LYG ABDNY LLPH LLPK LLPJ LLPE LLOBF LLPD LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 ABDNF LLD2 SLFPY

11
Schroders Plc and Lloyds Banking Group in talks over wealth management alliance

2018-10-07 channelnewsasia
Britain's Lloyds Banking Group is to merge its 13 billion pounds (US$17.06 billion) wealth management arm into a new joint venture with asset manager Schroders Plc , Sky news reported on Sunday.
SLFPF LLOY ADN SL LYG ABDNY LLPH LLPK LLPJ LLPE LLOBF LLPD LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 ABDNF LLD2 SLFPY

11
Schroders Plc and Lloyds Banking Group in talks over wealth management alliance

2018-10-07 reuters
(Reuters) - Asset manager Schroders Plc (SDR.L) and Lloyds Banking Group (LLOY.L) said on Sunday they were in discussions over a wealth management alliance.
SLFPF LLOY ADN SL LYG ABDNY LLPH LLPK LLPJ LLPE LLOBF LLPD LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 ABDNF LLD2 SLFPY

 
Standard Life Aberdeen adds to its AEM stake

2018-10-07 businesstimes.com.sg
FOR the five trading sessions ended Oct 4, the Straits Times Index (STI) ended marginally lower with a 0.1 per cent decline.
EXA EXAI SLFPF BLH GTHKF 5G1 ADN SL ATIN S21 GBYLF BEW 40F ABDNY K75 K2LU GBYLY AWX G50 ABDNF SLFPY

11
UPDATE 2-Schroders and Lloyds in talks on working together in wealth sector

2018-10-07 reuters
Oct 7 (Reuters) - Asset manager Schroders Plc and Lloyds Banking Group are in discussions to work together in the wealth sector, the two British companies said.
SLFPF LLOY ADN SL LYG ABDNY LLPH LLPK LLPJ LLPE LLOBF LLPD LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 ABDNF LLD2 SLFPY

 
UPDATE 3-Italy yields hit 4-1/2-yr high as lawmaker sparks euro exit fears

2018-10-02 reuters
LONDON (Reuters) - Italy’s 10-year bond yield soared to a 4-1/2 year high on Tuesday after an Italian lawmaker said that most of the country’s problems would be solved by ditching the euro, deepening market concerns over its public finances.
ABDNY ADN ABDNF

 
UPDATE 2-Italy bond yields surge to 4-1/2-yr highs as League lawmaker favours own currency

2018-10-02 reuters
* Euro zone periphery govt bond yields tmsnrt.rs/2ii2Bqr (Adds quote, updates price action, move in euro, Italian stocks)
ABDNY ADN ABDNF

 
‘America First’ risks making US assets a costly last resort

2018-08-23 malaymail
NEW YORK, Aug 23 — America First seems to have become an investment theme by default, as money managers turn to the US in a fraught global environment. The danger is that these flows may be concealing risks in the world’s safe haven.
ABDNY IFK IFX ADN ABDNF

11
Standard Life Aberdeen bosses defend tie-up as £16bn flows out the door

2018-08-07 telegraph.co.uk
The bosses of Standard Life Aberdeen have defended the rationale behind their £11bn merger as billions of pounds continues to head for the door.
SLFPF LLOY ADN SL LYG ABDNY LLPH LLPK LLPJ LLPE LLOBF LLPD LLPG LLDTF LLD5 LLD7 LLPC LLD6 LLD1 ABDNF LLD2 SLFPY

 
Deepak Parekh: HDFC investors voted against me due to directorship in many firms

2018-08-01 livemint
Mumbai: Deepak Parekh, the chairman of mortgage lender Housing Finance Development Corp. Ltd (HDFC), said that the company’s investors had voted against his reappointment on the recommendation of a US proxy advisory firm, which cited his directorship in many listed companies as one of the reasons for negative voting. In an exclusive interview with Mint, Parekh said that Institutional Shareholder Services LC (ISS), the proxy advisory firm which had asked HDFC shareholders to vote against his reappointment, had made similar recommendations in the past as well.
ABDNY VED ADN 500850 ABDNF INDHOTEL

11
Outflows Rock Fund Managers as Europe's $1 Trillion Dream Fades

2018-07-31 theedgemarkets
(July 31): Asset managers across Europe have long had their work cut out, with margins being squeezed and regulations pushing up costs. Now add this to their headaches: client redemptions.
HRGLY DB ADN SL AMUN HL LLOBF ABDNF SLFPF LLOY JUP LYG MORN ABDNY LLPH LLPK LLPJ LLPE LLPD LLPG HRGLF LLDTF LLD5 LLD7 LLPC LLD6 LLD1 LLD2 SLFPY

9
Royce, Ellsworth And India

2018-07-30 seekingalpha
In a July 2 article, "Screening Closed End Funds," I shared my strategy for adding up to 5 closed end funds to the portfolio. Seven CEFs were identified for my watchlist, including:
IFN MNXCZ GBL DISH ADN RMT MLAB RVT.WI ABDNY HEI.A KWR FLIR HEI MSFT MS RVT ABDNF

 
City veteran Anne Richards quits M&G for top Fidelity job ahead of Pru overhaul

2018-07-27 telegraph.co.uk
City veteran and former nuclear physicist Anne Richards has quit M&G Investments for the top job at Fidelity International amid a raft of management changes.
ABDNY ADN ABDNF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to LSE:ADN / ABERDEEN ASSET MANAGEMENT PLC on message board site Silicon Investor.

2018 NCAA College Basketball March Madness 2018 NCAA College Basketball March Madness 2018 NCAA College Basketball March Madness 2017 NCAA College Basketball March Madness 2017 NCAA College Basketball March Madness 2017 NCAA College Basketball March Madness
REFR madness: Asencio reports on Research Frontiers Inc REFR madness: Asencio reports on Research Frontiers Inc REFR madness: Asencio reports on Research Frontiers Inc 2016 NCAA College Basketball March Madness 2016 NCAA College Basketball March Madness 2016 NCAA College Basketball March Madness
2015 NCAA College Basketball March Madness 2015 NCAA College Basketball March Madness 2015 NCAA College Basketball March Madness 2014 NCAA College Basketball March Madness 2014 NCAA College Basketball March Madness 2014 NCAA College Basketball March Madness
2012 NCAA College Basketball March Madness 2012 NCAA College Basketball March Madness 2012 NCAA College Basketball March Madness 2013 NCAA College Basketball March Madness 2013 NCAA College Basketball March Madness 2013 NCAA College Basketball March Madness
Reefer Gladness Reefer Gladness Reefer Gladness 2011 NCAA College Basketball March Madness 2011 NCAA College Basketball March Madness 2011 NCAA College Basketball March Madness